Methods of treating neurodegenerative disorders using protease inhibitors
    7.
    发明授权
    Methods of treating neurodegenerative disorders using protease inhibitors 失效
    使用蛋白酶抑制剂治疗神经变性疾病的方法

    公开(公告)号:US5872101A

    公开(公告)日:1999-02-16

    申请号:US444361

    申请日:1995-05-18

    摘要: Methods of use of compounds and compounds for the treatment of disorders characterized by the cerebral deposition of amyloid are provided. Among the compounds are those of formulae (I), (II) and (III): ##STR1## in which R.sub.1 is preferably 2-methyl propene, 2-butene, norleucine; R.sub.2, R.sub.4, and R.sub.8 are each independently methyl or ethyl; R.sub.3 is preferably iso-butyl or phenyl; R.sub.5 is preferably iso-butyl; R.sub.6 is H or methyl; R.sub.7 --(Q).sub.n is preferably benzyloxycarbonyl or acetyl; Q is preferably --C(O)--; R.sub.8 is preferbly iso-butyl; R.sub.A =--(T).sub.m --(D).sub.m --R.sub.1, is which T is preferably oxygen or carbon, and D is preferably a mono-unsaturated C.sub.3-4 alkenyl being more preferred; and X is an alcohol, particularly a secondary alcohol.

    摘要翻译: 提供了化合物和化合物用于治疗以沉淀淀粉样蛋白为特征的疾病的方法。 其中R 1优选为2-甲基丙烯,2-丁烯,正亮氨酸;式(I),(II)和(III)的化合物为: R2,R4和R8各自独立地是甲基或乙基; R3优选为异丁基或苯基; R5优选为异丁基; R6是H或甲基; R7-(Q)n优选为苄氧羰基或乙酰基; Q优选为-C(O) - ; R8优选为异​​丁基; RA = - (T)m-(D)m -R 1,其中T优选为氧或碳,D优选为单不饱和C 3-4烯基; X是醇,特别是仲醇。

    Peptide, peptide analog and amino acid analog protease inhibitors
    8.
    发明授权
    Peptide, peptide analog and amino acid analog protease inhibitors 失效
    肽,肽类似物和氨基酸类似蛋白酶抑制剂

    公开(公告)号:US6017887A

    公开(公告)日:2000-01-25

    申请号:US443931

    申请日:1995-05-18

    摘要: Methods of use of compounds and compounds for the treatment of disorders characterized by the cerebral deposition of amyloid are provided. Among the compounds are those of formulae (I), (II) and (III): ##STR1## in which R.sub.1 is preferably 2-methyl propene, 2-butene, norleucine; R.sub.2, R.sub.4, and R.sub.8 are each independently methyl or ethyl; R.sub.3 is preferably iso-butyl or phenyl; R.sub.5 is preferably iso-butyl; R.sub.6 is H or methyl; R.sub.7 --(Q).sub.n is preferably benzyloxycarbonyl or acetyl; Q is preferably --C(O)--; R.sub.B is preferbly iso-butyl; R.sub.A =--(T).sub.m --(D).sub.m --R.sub.1, is which T is preferably oxygen or carbon, and D is preferably a mono-unsaturated C.sub.3-4 alkenyl being more preferred; and X is an alcohol, particularly a secondary alcohol.

    摘要翻译: 提供了化合物和化合物用于治疗以沉淀淀粉样蛋白为特征的疾病的方法。 其中R 1优选为2-甲基丙烯,2-丁烯,正亮氨酸等;式(I),(II)和(III) R2,R4和R8各自独立地是甲基或乙基; R3优选为异丁基或苯基; R5优选为异丁基; R6是H或甲基; R7-(Q)n优选为苄氧羰基或乙酰基; Q优选为-C(O) - ; RB优选为异丁基; RA = - (T)m-(D)m -R 1,其中T优选为氧或碳,D优选为单不饱和C 3-4烯基; X是醇,特别是仲醇。